Effect of filaggrin loss-of-function mutations on atopic dermatitis in young age: a longitudinal birth cohort study

J Hum Genet. 2019 Sep;64(9):911-917. doi: 10.1038/s10038-019-0628-y. Epub 2019 Jun 28.

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin disease, and skin barrier defects are often observed in patients with AD. So far, few association studies between FLG loss-of-function mutations and onset of AD in longitudinal studies of early childhood have been reported. In the present study, we aimed to investigate the effect of FLG loss-of-function mutations on the development of AD in a longitudinal birth cohort study. The status of AD diagnosis at each age until 6 years was collected from the Tokyo Children's Health, Illness, and Development (T-CHILD) study. We analyzed eight loss-of-function mutations in FLG in 712 participants. FLG loss-of-function mutations were significantly associated with AD onset in infancy (≤2 years) (P < 0.001, OR 3.54, 95% CI 1.88-6.65), but not with AD onset in childhood (≥3 years) (P = 0.981, OR 0.99, 95% CI 0.29-3.36), and none of the children in the present cohort who developed AD at 5 years of age or later carried FLG loss-of-function mutations. Our data support the notion that the effect of FLG loss-of-function mutations is prominent during a very early stage of life.

Publication types

  • Multicenter Study
  • Pragmatic Clinical Trial

MeSH terms

  • Child
  • Child, Preschool
  • Dermatitis, Atopic* / genetics
  • Dermatitis, Atopic* / metabolism
  • Dermatitis, Atopic* / pathology
  • Female
  • Filaggrin Proteins
  • Follow-Up Studies
  • Humans
  • Infant
  • Longitudinal Studies
  • Loss of Function Mutation*
  • Male
  • S100 Proteins / genetics*
  • S100 Proteins / metabolism

Substances

  • FLG protein, human
  • Filaggrin Proteins
  • S100 Proteins